Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0Q2SI
|
||||
Former ID |
DNC013020
|
||||
Drug Name |
4-(4-chlorobenzyl)phthalazin-1(2H)-one
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [1] | ||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C15H11ClN2O
|
||||
Canonical SMILES |
C1=CC=C2C(=C1)C(=NNC2=O)CC3=CC=C(C=C3)Cl
|
||||
InChI |
1S/C15H11ClN2O/c16-11-7-5-10(6-8-11)9-14-12-3-1-2-4-13(12)15(19)18-17-14/h1-8H,9H2,(H,18,19)
|
||||
InChIKey |
NLXGCQIEVZYDRS-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Alpha-1D adrenergic receptor | Target Info | Inhibitor | [1] | |
Alpha-1A adrenergic receptor | Target Info | Inhibitor | [1] | ||
KEGG Pathway | Calcium signaling pathway | ||||
cGMP-PKG signaling pathway | |||||
Neuroactive ligand-receptor interaction | |||||
Adrenergic signaling in cardiomyocytes | |||||
Vascular smooth muscle contraction | |||||
Salivary secretionhsa04020:Calcium signaling pathway | |||||
AMPK signaling pathway | |||||
Salivary secretion | |||||
NetPath Pathway | IL2 Signaling Pathway | ||||
PANTHER Pathway | Alpha adrenergic receptor signaling pathway | ||||
Reactome | Adrenoceptors | ||||
G alpha (q) signalling events | |||||
G alpha (12/13) signalling eventsR-HSA-390696:Adrenoceptors | |||||
G alpha (12/13) signalling events | |||||
WikiPathways | Monoamine GPCRs | ||||
Calcium Regulation in the Cardiac Cell | |||||
GPCRs, Class A Rhodopsin-like | |||||
Gastrin-CREB signalling pathway via PKC and MAPK | |||||
GPCR ligand binding | |||||
GPCR downstream signaling | |||||
GPCRs, OtherWP58:Monoamine GPCRs | |||||
Endothelin Pathways | |||||
AMPK Signaling | |||||
References | |||||
REF 1 | Bioorg Med Chem Lett. 2006 May 15;16(10):2786-90. Epub 2006 Mar 2.Vasorelaxant activity of phthalazinones and related compounds. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.